Goal 2: Reduce Human Disease

How can we increase the pharmaceutical clinical research of targeted therapies in pediatric PAH patients, including encouraging

Clinical research, especially randomized pharmaceutical clinical trials, poses many unique challenges compared to research in adult subjects. In pulmonary arterial hypertension, a disease characterized by high blood pressure of the lungs with increased pulmonary vascular resistance leading to right ventricular failure, there are 12 FDA-approved PAH-targeted therapies for adults. None of these medications are currently approved for use in children; however the non-approved medications are frequently used off-label in pediatric patients despite physiologic differences of adults and children and the lack of pediatric clinical trial data.

Tags (Keywords associated with the idea)


66 net votes
76 up votes
10 down votes
Idea No. 773